Home / Street Sector / Stocks Aim To Attain Analyst Attentions: Huntington Bancshares Incorporated (NASDAQ:HBAN), Progressive Corp. (NYSE:PGR)

Stocks Aim To Attain Analyst Attentions: Huntington Bancshares Incorporated (NASDAQ:HBAN), Progressive Corp. (NYSE:PGR)

Huntington Bancshares Incorporated (NASDAQ:HBAN) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with -0.39% to $10.12. The HBAN held a rough session during the week but was ready to get some critical analysis. The stock was assessed by a pool of analysts at WSJ and came out with some serious outcomes not to be avoided before making investment. The HBAN ratings chart showed that 15 gave HOLD ratings for the current month as 1 analyst opting for Overweight option for same period, whereas, 1 analyst out of pool gave UNDERWEIGHT rating. For stocks’ current month, 9 analysts opted for BUY ratings as compared to 0 opting for SELL in the same period. The stock price target chart showed average price target of 10.54 as compared to current price of 10.16.

Taking look on per share earnings estimates, its next year first quarter current estimate trend for EPS was for $0.21 and on annual basis FY 2016 estimate trends at current was for $0.82 as compared to one month ago of $0.82, and for next year per share earnings estimates have $0.88.

The share price of HBAN attracts active investors, as stock price of week volatility recorded 2.06%. The stock is going forward to its 52-week low with 32.10% and lagging behind from its 52-week high price with -12.32%.

Progressive Corp. (NYSE:PGR) [Trend Analysis] moved up reacts as active mover, shares an advance 0.58% to traded at $31.21 and the percentage gap between open changing to regular change was 0.00%. Lets us look over what analysts have to say about performance of the PGR. Starting with EPS for the final quarter of this year. EPS is usually the indicator of profitability for the company. According to WSJ analysis, the Q4 2016 current estimates trends were for $0.36 as compared to the next year Q1 current trend of $0.50. While on annual basis the current EPS estimates trend for FY 2017 came in for $2.02 as compared to three months ago $2.00.

The stock prices target chart showed high target of 40 kept by analysts at WSJ while the average price target was for 32.50 as compared to current price of 31.03. Somehow, the stock managed to gain BUY ratings by 5 analysts in current tenure as 1 analyst having overweight ratings, 11 recommend as HOLD, 6 gave it as a SELL security for current period. Overall, the consensus ratings were for Hold by the pool of analysts.

The firm past twelve months price to sales ratio was 0.81 and price to cash ratio remained 132.99. As far as the returns are concern, the return on equity was recorded as 14.00% and return on investment was 14.40% while its return on asset stayed at 3.50%. The firm has total debt to equity ratio measured as 0.34.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Recommended Momentum ‘How’ and ‘Why’: PPG Industries (NYSE:PPG), Allergan (NYSE:AGN)

PPG Industries, Inc. (NYSE:PPG) [Trend Analysis] try to make new thrust in street and making different …

Leave a Reply

Your email address will not be published. Required fields are marked *